Årsrapport 2022
Selskabsmeddelelse nr. 2 – 2023
København, den 23. marts 2023
Årsrapport 2022
Bestyrelsen i NTR Holding A/S har i dag behandlet og godkendt Selskabets årsrapport for regnskabsåret 2022. Årsrapporten har følgende hovedpunkter:
- NTR Holding koncernens salg af Daniamant A/S og Daniamant Ltd. blev gennemført den 31. januar 2022.
- Hovedparten af provenuet fra salget af Daniamant er udbetalt som udbytte. NTR Holding A/S har således i 2022 udbetalt udbytte på i alt DKK 49 pr. aktie, svarende til et samlet udbytte på DKK 121 mio. Bestyrelsen foreslår, at der ikke udloddes yderligere udbytte for 2022.
- Koncernens resultat af primær drift udviser et underskud på DKK 2,5 mio. (DKK -1,9 mio. i 2021), hvilket er i overensstemmelse med de senest udmeldte resultatforventninger.
- Koncernens totalindkomst udgør DKK 1,1 mio.
- Egenkapitalen udgør DKK 12,9 mio., svarende til en indre værdi pr. aktie på DKK 5,2.
- Bestyrelsen vil fortsat sondere NTR Holding A/S’ strategiske muligheder, herunder for at kapitalisere værdien af selskabets børsplatform.
- Under hensyn til den begrænsede driftsaktivitet, vil koncernen i stedet for en delårsrapport fremover offentliggøre en kvartalsorientering for 1. og 3. kvartal.
- NTR Holding-koncernen forventer i 2022 en omsætning på DKK 0 mio. og et underskud af primær drift i niveauet DKK 2 mio.
Årsrapporten kan downloades fra Selskabets hjemmeside, www.ntr.dk.
For yderligere information kontakt:
Ole Mikkelsen, direktør, e-mail: om@ntr.dk, mobil: +45 30 66 96 30
Vedhæftede filer
For at se dette indhold fra www.globenewswire.com, så skal du give din accept på toppen af denne side.For at se dette indhold fra ml-eu.globenewswire.com, så skal du give din accept på toppen af denne side.
Information om GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg pressemeddelelser fra GlobeNewswire by notified
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra GlobeNewswire by notified
Report for the first quarter of 202330.5.2023 19:43:43 CEST | Press release
Oslo, 30 May 2023 Highlights in the period Gross production in Q1 2023 decreased 21% compared to Q4 2022.In January 2023, the Company timely paid accrued and due interest on its corporate bond. Early in February 2023, the Company was notified of the formal approval to its acquisition of the 8.34% participating interests in five concessions in Santa Cruz, Argentina where the Company also serves as operator. The Company has worked with the relevant Provincial authorities on the satisfaction of the requirements to restart full activities in the MMO and Cañadón Ramírez fields (Chubut, Argentina) and reopened such fields. For more information, please see enclosed Interoil Exploration and Production ASA's Report for the first quarter of 2023. This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act. *************************** Please direct any further questions to ir@interoil.no (mailto:ir@interoil.no) About Interoil Intero
Change in management30.5.2023 19:41:51 CEST | Press release
The board of directors and CEO/CFO Anders Fink Vadsholt has today entered into a severance agreement pursuant to which Mr. Vadsholt will step down as CEO/CFO of the Company. Regardless, Mr. Vadsholt will remain available for the company until his replacement has been found and all disputes related to the US security class action case has been finally settled, however, in no event longer than until 1 October 2023. Anders Fink Vadsholt states:” With the latest progress in our US security class action case described in company announcement of 17 April 2023, and a successful sale and hand over of all activities to Zevra Therapeutics (Previously Kempharm), I see my job as CEO/CFO successfully completed and the time has come for me to look for new challenges. I would like to thank all former colleagues in Orphazyme for years of dedicated work and loyalty”. Chairman Michael Hove states: On behalf of the board, I would like to thank Mr. Vadsholt for his dedicated work especially during the pas
Transfer of Harvia's own shares as rewards under the incentive program30.5.2023 19:35:00 CEST | Press release
Harvia Plc, Stock Exchange Release, May 30, 2023 at 8:35 p.m. EEST The Board of Directors of Harvia Plc has on 3 May 2023 decided on a directed share issue without consideration for the payment of rewards earned under the company’s share-based incentive program. The share payments concern the performance period 2020–2022 of the company’s share-based incentive program launched in 2020. In the share issue, 9,109 own shares held by the company have today been transferred without consideration to the key employees participating in the share-based incentive program in accordance with the program-specific terms and conditions. After the transfer of shares under the incentive program and the shares transferred at the same time as part of the board remuneration, the company holds a total of 9,637 own shares. The decision on the transfer of shares is based on the authorization granted to the Board of Directors by the Annual General Meeting on 20 April 2023. No new shares shall be issued in conn
Transfer of Harvia’s own shares as part of remuneration of the Board30.5.2023 19:30:00 CEST | Press release
Harvia Plc, Stock Exchange Release, 30 May 2023 at 8:30 p.m. EEST Based on the decision of the General Meeting held 20 April 2023, Harvia Oyj has on 30 May 2023 transferred a total of 2,328 own shares possessed by the company to members of the Board of Directors of Harvia Oyj as part of the Board’s remuneration. After the transfer of shares as part of the board remuneration and the shares transferred at the same time under the incentive program, the company holds a total of 9,637 own shares. Based on the decision of the General Meeting of Harvia Oyj, the monthly remuneration of the Board members will be paid in company shares and in cash in such a way that approximately 40 per cent of the total monthly remuneration will be paid in company shares purchased at a price determined in public trading on Nasdaq Helsinki Ltd and approximately 60 per cent will be paid in cash. The company will pay any costs and transfer tax related to the purchase of company shares. In case the remuneration can
Vesting af warranter samt ledende medarbejderes transaktioner30.5.2023 19:18:09 CEST | pressemeddelelse
Selskabet har dags dato modtaget meddelelse om at Direktion og bestyrelse ønsker at exercise ialt 5.983.524 stk. warranter fra tildelingsåret maj 2020 (Selskabsmeddelelse 20/2020). Warrantprogrammet blev tildelt direktion og bestyrelse i maj 2020, og indehaverne af warranterne udnytter nu deres respektive programmer, og herefter udestår ingen aktieoptioner fra tildelingsåret maj 2020. Udnyttelseskursen er ved tildelingen i maj 2020 fastsat til DKK 1,53 pr. aktie af nominelt DKK 0,5, jf. selskabsmeddelelse 20/2020. Selskabet har som led i udnyttelsen af aktieoptionerne afhændet 5.983.524 stk. egne aktier til et samlet beløb på DKK 9.154.791,72, og således foretages der ingen kapitalforhøjelse i forbindelse med udnyttelsen af aktieoptionerne. Selskabets egen aktiebeholdning er efter frasalget reduceret til i alt 0 aktier. I forbindelse med gennemførelsen af ovenstående transaktioner har selskabet modtaget vedhæftede indberetninger fra direktionen og bestyrelsens respektive transaktioner.